REDUCTION OF WHOLE-BLOOD SEROTONIN IN DEPRESSED-PATIENTS TREATED WITH A NEW, SELECTIVE SEROTONIN-UPTAKE INHIBITOR, FEMOXETINE

被引:20
作者
BORUP, C
PETERSEN, IM
LEFEVREHONORE, P
WETTERBERG, L
机构
[1] AS FERROSAN, DEPT CLIN, SYDMARKEN 5, DK-2860 Soborg, DENMARK
[2] ST GORANS HOSP, KAROLINSKA INST, DEPT PSYCHIAT, S-11281 STOCKHOLM, SWEDEN
[3] ST HANS MENTAL HOSP, DEPT F, DK-4000 ROSKILDE, DENMARK
关键词
5-HT-Uptake inhibition; Antidepressant effect; Femoxetine; Thrombocytes;
D O I
10.1007/BF00433556
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Femoxetine, a phenylpiperidine derivative with potent serotonin (5-HT)-uptake inhibitory properties, was studied in 12 depressive patients for its clinical effect and its effect on 5-HT concentration in whole blood. The global evaluation after 6 wk showed a good effect in 6 patients. The 5-HT concentration was reduced from a mean value of 0.21 to about 0.05 .mu.g/ml, indicating a total depletion of 5-HT from the thrombocytes. The steady-state concentrations of femoxetine reduced 5-HT to the same level in all patients. No correlation between degree of 5-HT reduction and therapeutic effect was found.
引用
收藏
页码:241 / 243
页数:3
相关论文
共 13 条
[1]   DETERMINATION OF (+)-(3R),(4S)-3-[(4-METHOXYPHENOXY)METHYL]-1-METHYL-4-PHENYLPIPERIDINEHYDROCHLORIDE (FG 4963) IN BIOLOGICAL-FLUIDS USING COMPETITION FOR ADSORPTION TO GLASS [J].
BECHGAARD, E ;
LUND, J .
JOURNAL OF CHROMATOGRAPHY, 1977, 133 (01) :147-152
[2]   NEUROCHEMICAL AND PHARMACOLOGICAL STUDIES ON A NEW 5HT-UPTAKE INHIBITOR, FG4963, WITH POTENTIAL ANTIDEPRESSANT PROPERTIES [J].
BUUSLASSEN, J ;
SQUIRES, RF ;
CHRISTENSEN, JA ;
MOLANDER, L .
PSYCHOPHARMACOLOGIA, 1975, 42 (01) :21-26
[3]   EFFECT OF ANTIDEPRESSANT DRUGS ON DEPLETION OF INTRANEURONAL BRAIN 5-HYDROXYTRYPTAMINE STORES CAUSED BY 4-METHYL-ALPHA-ETHYL-META-TYRAMINE [J].
CARLSSON, A ;
CORRODI, H ;
FUXE, K ;
HOKFELT, T .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1969, 5 (04) :357-&
[4]  
GARATTINI J, 1965, SEROTONIN, P57
[5]   FACTORS INFLUENCING FREE SEROTONIN IN HUMAN PLASMA [J].
GENEFKE, IK ;
GAREL, A ;
MANDEL, P .
CLINICA CHIMICA ACTA, 1968, 20 (01) :61-&
[6]   ANTIDEPRESSANT EVALUATION AND PHARMACOLOGICAL ACTIONS OF FG4963 IN DEPRESSIVE PATIENTS [J].
GHOSE, K ;
GUPTA, R ;
COPPEN, A ;
LUND, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1977, 42 (01) :31-37
[7]   A RATING SCALE FOR DEPRESSION [J].
HAMILTON, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (01) :56-62
[8]  
HELTBERG J, 1975, NORD PSYKIAT TIDSSKR, V29, P485
[9]   EFFECT OF IPRONIAZID AND IMIPRAMINE ON THE BLOOD PLATELET 5-HYDROXYTRYPTAMINE LEVEL IN MAN [J].
MARSHALL, EF ;
STIRLING, GS ;
TAIT, AC ;
TODRICK, A .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1960, 15 (01) :35-41
[10]   DECREASED BLOOD LEVEL OF 5-HYDROXYTRYPTAMINE BY INHIBITORS OF MEMBRANAL 5-HYDROXYTRYPTAMINE UPTAKE [J].
ROSS, SB ;
JANSA, S ;
WETTERBERG, L ;
FYRO, B ;
HELLNER, B .
LIFE SCIENCES, 1976, 19 (02) :205-210